Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness

Prostate cancer accounts for approximately 13.5% of all newly diagnosed male cancer cases. Significant clinical burdens remain in terms of ineffective prognostication, with overtreatment of insignificant disease. Additionally, the pathobiology underlying disease heterogeneity remains poorly understo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Flynn, Louise, Barr, Martin P., Baird, Anne-Marie, Smyth, Paul, Casey, Orla M., Blackshields, Gordon, Greene, John, Pennington, Stephen R., Hams, Emily, Fallon, Padraic G., O’Leary, John, Sheils, Orla, Finn, Stephen P.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7347552/
https://ncbi.nlm.nih.gov/pubmed/32647229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-68187-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados